Randomized Controlled Trial
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 6, 2022; 10(31): 11427-11441
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11427
Table 4 Comparison within and between groups for gastrointestinal symptoms
Measure
Intervention group (n = 32)
Control group (n = 32)
Between-group difference
Mean difference (95%CI)
P value
Mean difference (95%CI)
P value
Mean difference (95%CI)
P value
Abdominal distension
T1ReferenceN/AReferenceN/A-0.2 (-0.5, 0.1)0.26
T2-0.2 (-0.5, -0.2)0.720.5 (0.2, 0.7)<0.001-0.8 (-1.1, -0.5)< 0.001
T3-0.7 (-1.0, -0.4)< 0.0010.2 (-0.3, 0.6)0.97-1.0 (-1.3, -0.7)< 0.001
Nausea
T1ReferenceN/AReferenceN/A0.1 (-0.2, 0.5)0.46
T2-0.6 (-0.9, -0.6)< 0.001-0.1 (-0.4, 0.2)1.00-0.5 (-0.8, -0.3)< 0.001
T3-1.0 (-1.3, -0.8)< 0.001-0.6 (-1.0, -0.2)0.002-0.3 (-0.5, -0.2)< 0.001
Vomiting
T1ReferenceN/AReferenceN/A0 (-0.3, 0.3)0.83
T2-0.2 (-0.4, 0)0.02-0.1 (-0.2, 0.1)1.00-0.2 (-0.4, 0.1)0.19
T3-0.3 (-0.5, 0)0.02-0.3 (-0.5, 0)0.06-0.1 (-0.2, 0)0.14
Fatigue
T1ReferenceN/AReferenceN/A-0.3 (-0.7, 0)0.04
T2-0.8 (-1.0, -0.5)< 0.001-0.2 (-0.4, 0)0.13-0.9 (-1.2, -0.6)< 0.001
T3-1.1 (-1.4, -0.9)< 0.001-0.7 (-0.9, -0.5)< 0.001-0.8 (-1.1, -0.5)< 0.001